Making HiStory pioneering scientific achievements for patients with moderate to severe Hidradenitis Suppurativa


Presented by Abbvie
Presented by Abbvie

During the Summer Meeting, AbbVie representatives reviewed its history in the Hidradenitis Suppurativa disease space. It explored morphological features and Hurley staging of HS, as well as reviewed the role of Humira as a treatment option for moderate to severe Hidradenitis Suppurativa.

For more information, visit https://dermatology.commercialusconventions.com/.